Bandaram Pharma reports FY26 profit, auditors flag subsidiary issues

2 min read     Updated on 31 May 2026, 01:45 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Bandaram Pharma Packtech Limited reported a consolidated net profit of ₹44.81 lakh for the financial year ended March 31, 2026, while standalone operations recorded a net loss of ₹115.91 lakh. The board approved the audited financial results on May 30, 2026. Statutory auditors M/s. M.M. Reddy & Co. issued an unmodified opinion on standalone results but a modified opinion on consolidated results due to accounting irregularities at subsidiary VSR Paper and Packaging Limited, specifically regarding the netting off of trade receivables and payables amounting to ₹1,240.80 lakh without sufficient documentation. The board also appointed M/s. MGR & Co. as internal auditors for FY 2026-27.

powered bylight_fuzz_icon
41717570

*this image is generated using AI for illustrative purposes only.

Bandaram Pharma Packtech Limited reported a consolidated net profit of ₹44.81 lakh for the financial year ended March 31, 2026, while its standalone operations recorded a net loss of ₹115.91 lakh for the same period. The company's board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026. The statutory auditors, M/s. M.M. Reddy & Co., issued an unmodified opinion on the standalone financial results but provided a modified opinion on the consolidated results, citing significant accounting irregularities at subsidiary VSR Paper and Packaging Limited.

The subsidiary recorded purchase and sale transactions with certain parties through the same ledger accounts, resulting in the netting off of trade receivables and payables. The auditors noted that management provided inadequate supporting documentation to establish the commercial substance of this treatment or the legal right of set-off for certain adjustments. Consequently, the auditors stated they were unable to obtain sufficient appropriate audit evidence regarding the completeness and accuracy of the adjusted trade receivables and payables, the validity of underlying transactions, and the consequential impact on the consolidated financial statements.

Financial Performance

For the full year FY26, the company reported a consolidated total income of ₹6,294.12 lakh, compared to ₹3,705.77 lakh in the previous year. On a standalone basis, total income stood at ₹1,096.82 lakh, down from ₹1,232.22 lakh in FY25. The consolidated figures include the financials of subsidiaries VSR Paper and Packaging Limited and Craftsmart Products Private Limited.

Key Financials (FY26)

Metric Standalone (₹ in lakh) Consolidated (₹ in lakh)
Total Income 1,096.82 6,294.12
Total Expenses 1,212.84 6,249.99
Net Profit/(Loss) (115.91) 44.81
Earnings Per Share (Basic) (0.64) 0.25

Auditor Observations

The auditors highlighted that sundry debtors and creditors amounting to ₹1,240.80 lakh were adjusted by offsetting with various parties in the subsidiary's books. Consequently, the auditors could not determine whether adjustments were necessary to the reported consolidated profit of ₹44.13 lakh or total assets of ₹7,586.25 lakh. The management stated that it has taken note of the auditors' opinion and will take necessary actions subsequently.

Board Decisions

Alongside the results, the board appointed M/s. MGR & Co., Chartered Accountants, as internal auditors for the financial year 2026-27. The company confirmed that the financial statements were prepared in compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, and Indian Accounting Standards.

Historical Stock Returns for Bandaram Pharma Packtech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-2.79%+0.32%-14.58%-22.47%+23.48%

What specific remedial actions does management plan to take to address the accounting irregularities identified at VSR Paper and Packaging Limited?

How will the modified audit opinion and potential restatements impact the company's ability to secure financing or maintain investor confidence in FY27?

Will the company restate its consolidated financial statements for FY26 once the audit evidence regarding the subsidiary's trade receivables and payables is obtained?

Bandaram Pharma Packtech
View Company Insights
View All News
like19
dislike

Bandaram unit secures Rs 3.87 crore order for textbook materials

0 min read     Updated on 29 May 2026, 05:25 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

VSR Paper and Packaging Limited, a material subsidiary of Bandaram Pharma Packtech Limited, has secured a work order worth Rs.3,86,85,410 from M/s S. A. Printers for supplying raw materials for printing textbooks. The order is for the academic year 2026-27 with an execution period from June to August 2026. The disclosure confirms the order is from a domestic entity and is not a related party transaction.

powered bylight_fuzz_icon
41600320

*this image is generated using AI for illustrative purposes only.

VSR Paper and Packaging Limited, a material subsidiary of Bandaram Pharma Packtech , has secured a work order worth Rs.3,86,85,410 from M/s S. A. Printers for supplying raw materials for printing textbooks. The order involves the supply of paper, board, and other materials required for the academic year 2026-27. The execution period is scheduled from June to August 2026.

Order Details

The order was awarded by a domestic entity, M/s S. A. Printers, and is classified as a domestic work order. The disclosure confirms that the promoters, promoter group, or group companies hold no interest in the entity awarding the orders. Furthermore, the transactions do not fall under related party transactions.

Particulars Description
Name of Client M/s S. A. Printers
Nature of Order Work Order
Order Value Rs.3,86,85,410/-
Execution Period June-August 2026
Related Party Transaction Not Applicable

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Deepak Bandaram, Chairman and Managing Director, signed the disclosure on behalf of Bandaram Pharma Packtech Limited.

Historical Stock Returns for Bandaram Pharma Packtech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-2.79%+0.32%-14.58%-22.47%+23.48%

How will this order impact VSR Paper and Packaging's revenue projections for the fiscal year 2026-27?

Does this contract signal a potential for recurring orders from M/s S. A. Printers in future academic years?

What are the margin expectations for supplying raw materials to the textbook printing sector compared to other segments?

Bandaram Pharma Packtech
View Company Insights
View All News
like20
dislike

More News on Bandaram Pharma Packtech

1 Year Returns:-22.47%